Literature DB >> 19376741

Hepatitis E virus in patients with unexplained hepatitis in Finland.

Tuija Kantala1, Leena Maunula, Carl-Henrik von Bonsdorff, Jaakko Peltomaa, Maija Lappalainen.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) is an important cause of enterically transmitted viral hepatitis, especially in developing countries. Recently, HEV isolates have been identified in humans also in industrialized countries, where it has been considered nonendemic.
OBJECTIVES: To investigate whether HEV is a cause of unexplained hepatitis in humans in Finland. STUDY
DESIGN: The prevalence of anti-HEV IgM and IgG and HEV RNA was determined in 105 serum samples from 97 patients diagnosed with acute unexplained hepatitis. Partial nucleotide sequences of the HEV isolates obtained were compared with reported sequences in GenBank.
RESULTS: Anti-HEV IgM and/or IgG by both ELISA test and immunoblotting were detected in 29 serum samples (27.6%) from 22 patients (22.7%). HEV RNA was detected in eight patient samples (8.2%) and partial nucleotide sequences were present in five of these. All five viruses belonged to HEV genotype 1, and three of them were from patients who had traveled to Asia.
CONCLUSION: These preliminary results indicate that HEV must be considered a possible cause of acute hepatitis in Finland.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376741     DOI: 10.1016/j.jcv.2009.03.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

1.  Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt.

Authors:  Jason T Blackard; Susan D Rouster; Soad Nady; Gehan Galal; Naglaa Marzuuk; Marwaa M Rafaat; Enas Daef; Salwa Seif El Din; Robert H Purcell; Suzanne U Emerson; Kenneth E Sherman; M Tarek Shata
Journal:  J Clin Virol       Date:  2009-08-03       Impact factor: 3.168

Review 2.  Autochthonous Hepatitis E Virus Infection in Europe: A Matter of Concern for Public Health?

Authors:  José-Manuel Echevarría
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

Review 3.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

Review 4.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

Review 5.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

6.  Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey.

Authors:  Arianne B van Gageldonk-Lafeber; Wim van der Hoek; Floor Borlée; Dick J J Heederik; Sofie H Mooi; Catharina B M Maassen; C Joris Yzermans; Barry Rockx; Lidwien A M Smit; Johan H J Reimerink
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

7.  Seroprevalence of Hepatitis E Virus in Moose (Alces alces), Reindeer (Rangifer tarandus), Red Deer (Cervus elaphus), Roe Deer (Capreolus capreolus), and Muskoxen (Ovibos moschatus) from Norway.

Authors:  Carlos Sacristán; Knut Madslien; Irene Sacristán; Siv Klevar; Carlos G das Neves
Journal:  Viruses       Date:  2021-02-01       Impact factor: 5.048

8.  Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.

Authors:  Aletta T R Tholen; Janke Schinkel; Richard Molenkamp; C Wim Ang
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

9.  Antibodies Against Hepatitis E Virus (HEV) in European Moose and White-Tailed Deer in Finland.

Authors:  Emil Loikkanen; Satu Oristo; Natalia Hämäläinen; Pikka Jokelainen; Tuija Kantala; Antti Sukura; Leena Maunula
Journal:  Food Environ Virol       Date:  2020-09-07       Impact factor: 2.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.